encyclopedia jump navigation jump search chronic obstructive pulmonary disease chronic obstructive pulmonary disease
occurrence ga tissue
term cough chronicbronchitis
chronic obstructive pulmonary disease name chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease loresjpg pathology lung chronic obstructive pulmonary disease characteristic smoke
close-up cut lung surface cavity carbon deposit
symptom breath cough sputum production complication exacerbation chronic obstructive pulmonary disease onset year duration term cause tobacco smoke air pollution genetics method lung function test diagnosis asthma prevention air quality treatment rehabilitation lung transplantation bronchodilator steroid oxygen therapy frequency death
chronic obstructive pulmonary disease chronic obstructive pulmonary disease type lung disease breath problem airflow symptom shortness breath cough sputum production chronic obstructive pulmonary disease disease mean time activity walk chronic obstructive pulmonary disease chronic obstructive pulmonary disease term type chronic obstructive pulmonary disease term chronic obstructive pulmonary disease cough month year year cough risk chronic obstructive pulmonary disease term chronic obstructive pulmonary disease presence air ga tissue
tobacco smoke cause chronic obstructive pulmonary disease factor air pollution genetics role world source air pollution heate cook fire exposure irritant response lung narrow airway breakdown lung tissue diagnosis airflow lung function test contrast asthma airflow reduction use bronchodilator
case chronic obstructive pulmonary disease exposure risk factor rate smoke air quality treatment cure chronic obstructive pulmonary disease treatment smoke cessation vaccination rehabilitation bronchodilator steroid people oxygen therapy lung transplantation period use medication hospitalization
chronic obstructive pulmonary disease people population people age male female death death death world number death smoke rate world population country cost content
sign symptom cough shortness breath symptom cause smoke air pollution exposure genetics diagnosis test diagnosis prevention smoke cessation health air pollution management exercise medication oxygen surgery epidemiology history society culture economics research animal reference read link
sign symptom
menu sound wheez stethoscope
problem file
symptom chronic obstructive pulmonary disease sputum production shortness breath cough symptom period time time type chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease chronic obstructive pulmonary disease description lung change disease chronic obstructive pulmonary disease descriptor symptom chronic obstructive pulmonary disease cough
cough symptom sputum cough month year year combination sputum production explanation definition chronic obstructive pulmonary disease chronic obstructive pulmonary disease airflow chronic obstructive pulmonary disease amount sputum hour day case cough people chronic obstructive pulmonary disease attribute symptom smoker cough factor cough rib fracture loss consciousness chronic obstructive pulmonary disease history cold time shortness breath
shortness breath symptom people breath effort breath cant air term culture shortness breath exertion duration time stage end stage disease rest source anxiety quality life chronic obstructive pulmonary disease people chronic obstructive pulmonary disease lip action shortness breath symptom
chronic obstructive pulmonary disease breath chest tightness problem airflow wheez sound air entry examination chest stethoscope barrel chest sign chronic obstructive pulmonary disease tripod position disease
chronic obstructive pulmonary disease pressure lung artery strain ventricle heart situation symptom leg swell neck vein chronic obstructive pulmonary disease lung disease cause use oxygen
chronic obstructive pulmonary disease number condition part risk factor condition heart disease blood pressure diabete mellitus muscle osteoporosis lung cancer anxiety disorder dysfunction depression disease feel chronic obstructive pulmonary disease investigation lung cancer
exacerbation chronic obstructive pulmonary disease shortness breath sputum production change color sputum green increase cough chronic obstructive pulmonary disease sign work breath breath heart rate use muscle neck tinge skin confusion behavior lung examination stethoscope cause
cause chronic obstructive pulmonary disease tobacco smoke exposure pollution fire cause country decade symptom person makeup risk smoke percentage female tobacco percentage male tobacco 2000
scale female male
risk factor chronic obstructive pulmonary disease tobacco smoke chronic obstructive pulmonary disease smoker half chronic obstructive pulmonary disease united states united kingdom chronic obstructive pulmonary disease 8095 smoker likelihood chronic obstructive pulmonary disease increase smoke exposure women effect smoke men non-smoker exposure smoke cause case type smoke marijuana cigar smoke risk smoke smoke cigarette problem marijuana smoke use women pregnancy risk chronic obstructive pulmonary disease child amount cigarette smoke women risk chronic obstructive pulmonary disease men air pollution
cook fire coal biomass fuel wood dung lead air pollution cause chronic obstructive pulmonary disease country fire method cook heate people health effect women exposure source energy home india china africa
people city rate chronic obstructive pulmonary disease people area air pollution factor exacerbation role cause chronic obstructive pulmonary disease area air quality exhaust ga rate chronic obstructive pulmonary disease effect relation smoke
exposure workplace dust chemical fume risk chronic obstructive pulmonary disease smoker nonsmoker workplace exposure cause case united states case risk country regulation
number industry source level dust coal mine gold mine cotton textile industry occupation cadmium isocyanate fume weld work agriculture risk profession risk equivalent pack cigarette day silica dust dust exposure chronic obstructive pulmonary disease risk silicosis effect dust exposure cigarette smoke exposure genetics
genetics play role development chronic obstructive pulmonary disease relative chronic obstructive pulmonary disease smoker risk factor alpha deficiency risk alpha case condition people factor
number factor chronic obstructive pulmonary disease
risk poverty risk factor poverty air pollution malnutrition evidence asthma airway hyperreactivity risk chronic obstructive pulmonary disease birth factor birth weight role number disease hivaid tuberculosis infection pneumonia risk chronic obstructive pulmonary disease adult
exacerbation worsen symptom infection pollutant factor use medication cause case bacteria viruse pollutant air quality exposure smoke smoke risk temperature role exacerbation winter disease exacerbation disease year year year exacerbation rate deterioration lung function embolism pe blood clot lung symptom chronic obstructive pulmonary disease sign pe chronic obstructive pulmonary disease chest pain heart failure sign infection left diagram lung airway inset cross-section bronchiole alveoly
right lung chronic obstructive pulmonary disease inset cross-section bronchiole alveoly
chronic obstructive pulmonary disease type lung disease airflow airflow limitation inability air trap airflow result breakdown lung tissue chronic obstructive pulmonary disease airway disease bronchiolitis contribution factor people destruction airway formation lung bullae lung tissue
form disease chronic obstructive pulmonary disease
chronic obstructive pulmonary disease response irritant infection state cell neutrophil granulocyte macrophage type blood cell
lymphocyte involvement people chronic obstructive pulmonary disease involvement asthma
part cell response mediator factor
process lung damage stress concentration radical tobacco smoke cell breakdown tissue lung protease protease inhibitor
destruction tissue lung chronic obstructive pulmonary disease airflow absorption release gase muscle chronic obstructive pulmonary disease mediator lung blood chronic obstructive pulmonary disease space lung tissue preservation right
narrowing airway inflammation scare
reduction air flow pressure chest airway time air breath lung breath increase volume air lung time process hyperinflation air trap exercise shortness breath chronic obstructive pulmonary disease breath lung exacerbation
degree airway irritant asthma
oxygen level carbon dioxide level blood ga exchange ventilation airway obstruction hyperinflation desire airway inflammation hyperinflation airflow worsen ga transfer
ventilation blood oxygen level oxygen level period narrow artery lung chronic obstructive pulmonary disease breakdown capillary lung
change result blood pressure artery diagnosis person sit device computer person spirometer
device office use
diagnosis chronic obstructive pulmonary disease age shortness breath cough sputum production winter cold history exposure risk factor disease spirometry diagnosis screen symptom
measure amount airflow obstruction present use bronchodilator medication airway component diagnosis volume second volume air second breath capacity volume air breath fvc second ratio symptom chronic obstructive pulmonary disease person disease measurement over-diagnosis chronic obstructive pulmonary disease institute health care excellence criteria fev1 people chronic obstructive pulmonary disease decrease capacity lung carbon monoxide surface area alveoly damage bed
evidence symptom effort condition effect peak flow speed expiration asthma diagnosis chronic obstructive pulmonary disease mrc shortness breath scale grade activity activity walk walk minute walk cloth gold grade gold
gold gold gold
number method chronic obstructive pulmonary disease individual research council questionnaire chronic obstructive pulmonary disease assessment test cat questionnaire severity symptom score cat range 040 score disease spirometry severity airflow limitation fev1 percentage person age gender height weight guideline treatment recommendation fev1 gold guideline people category symptom assessment airflow limitation weight loss muscle weakness presence disease account test
chest x-ray blood count condition time diagnosis characteristic sign x-ray lung diaphragm airspace bullae lung disease pneumonia pneumothorax tomography scan chest distribution chronic obstructive pulmonary disease lung lung disease surgery management trachea deformity analysis blood need oxygen fev1 oxygen saturation symptom heart failure area world antitrypsin deficiency people chronic obstructive pulmonary disease age chronic obstructive pulmonary disease part lung test
image heart middle lung
chest x-ray chronic obstructive pulmonary disease heart size comparison lung
chest x-ray person chronic obstructive pulmonary disease note barrel chest flat diaphragm
lung chest x-ray person chronic obstructive pulmonary disease
case chronic obstructive pulmonary disease
ct image lung person chronic obstructive pulmonary disease
chronic obstructive pulmonary disease lung cancer ct scan
chronic obstructive pulmonary disease cause shortness breath heart failure embolism pneumonia pneumothorax
people chronic obstructive pulmonary disease asthma distinction asthma chronic obstructive pulmonary disease basis symptom smoke history airflow limitation bronchodilator tuberculosis cough location condition dysplasia chronic obstructive pulmonary disease airflow situation chronic obstructive pulmonary disease prevention
case chronic obstructive pulmonary disease exposure smoke air quality influenza vaccination chronic obstructive pulmonary disease death vaccination diet beta-carotene supplement review haemophilus vaccine exacerbation year baseline chronic obstructive pulmonary disease reduction smoke cessation
people start smoke aspect chronic obstructive pulmonary disease policy government health agency organization smoke rate people start people smoke smoke ban area place work measure decrease exposure smoke place ban
stop smoke measure worsen chronic obstructive pulmonary disease stage disease rate lung function delay onset disability death attempt abstinence attempt year lead success people
smoker smoke cessation willpower
smoke smoker support
chance support engagement smoke cessation program use medication nicotine replacement therapy medication therapy people chronic obstructive pulmonary disease stop smoke therapy health
number measure likelihood worker industriessuch coal mine construction chronic obstructive pulmonary disease example measure creation policy education worker management risk smoke cessation worker sign chronic obstructive pulmonary disease use respirator dust control dust control ventilation water spray mine technique dust generation worker chronic obstructive pulmonary disease lung damage dust exposure example work role air pollution
air quality chronic obstructive pulmonary disease worsen disease policy effort change involvement
number country air quality regulation
improvement lung function population chronic obstructive pulmonary disease symptom day air quality
effort exposure smoke cook heate fuel ventilation home stove chimney stove air quality
energy source cook heate
fuel kerosene coal biomass wood dung management
cure chronic obstructive pulmonary disease symptom progression goal management risk factor chronic obstructive pulmonary disease exacerbation illness measure mortality cessation oxygen smoke risk death recommendation influenza vaccination year vaccination year reduction exposure air pollution disease palliative care symptom morphine feel shortness breath ventilation support breath people action plan session support use action plan event exacerbation number hospital visit treatment exacerbation self-management intervention corticosteroid oxygen action plan quality life care exercise
rehabilitation program exercise disease management individual exacerbation rehabilitation quality life ability exercise rehabilitation mortality rate hospital readmission rate rehabilitation sense control person disease emotion
exercise routine use ventilation exercise intensity exercise people chronic obstructive pulmonary disease perform endurance arm exercise arm movement people chronic obstructive pulmonary disease improvement breathlessness perform arm exercise quality life breath exercise role lip breath exercise tay chy exercise practice people chronic obstructive pulmonary disease function capacity treatment program tai chi exercise intervention program muscle train method activity live
combination imt walk exercise home limit breathlessness case chronic obstructive pulmonary disease use amplitude velocity mobilization exercise lung function exercise capacity goal manipulation therapy smt mobility effort work lung respiration turn increase exercise capacity result review
symptom degree disability prognosis chronic obstructive pulmonary disease
people chronic obstructive pulmonary disease breath muscle strength calorie intake exercise rehabilitation program improvement chronic obstructive pulmonary disease symptom
bronchodilator medication result benefit type
agonist anticholinergics long-act form shortness breath wheeze exercise limitation quality life progression disease
disease agent basis disease agent agent hyperinflation bronchodilator corticosteroid type agent long-act beta agonist laba work type agent risk exacerbation time benefit significance
agonist salbutamol relief symptom hour salmeterol maintenance therapy
evidence benefit evidence benefit use chronic obstructive pulmonary disease effect heart palpitation steroid risk pneumonia steroid laba benefit risk evidence treatment laba antagonist anticholinergic pneumonia improvement volume improvement quality life treatment laba corticosteriod ics ics evidence benefit dose day long-act
agonist drug dose people chronic obstructive pulmonary disease
anticholinergics chronic obstructive pulmonary disease ipratropium tiotropium
decrease exacerbation quality life tiotropium benefit mortality hospitalization rate mouth tract symptom risk heart disease stroke agent chronic obstructive pulmonary disease quality life lama bromide alternative tiotropium aclidinium level efficacy placebo research corticosteroid
form tablet exacerbation
corticosteroid benefit people chronic obstructive pulmonary disease exacerbation disease effect mortality progression disease combination laba mortality icss inhal steroid rate pneumonia treatment tablet side effect medication
antibiotics class frequency exacerbation year practice area world concern potential antibiotic resistance side effect hear loss tinnitus change heart rhythm qt syndrome theophylline harm benefit agent measure people chronic obstructive pulmonary disease need update cough medicine
people chronic obstructive pulmonary disease use heart-specific therapy function therapy people chronic obstructive pulmonary disease oxygen
oxygen oxygen level rest pressure oxygen mmhg oxygen saturation group people risk heart failure death hour day people ability exercise oxygen level oxygen supplementation shortness breath exercise breathlessness activity quality life risk fire benefit oxygen situation use exacerbation oxygen therapy use concentration oxygen account person oxygen level carbon dioxide outcome risk carbon dioxide level oxygen saturation 8892 risk level surgery
disease surgery lung transplantation lung surgery part lung chronic obstructive pulmonary disease lung chronic obstructive pulmonary disease lobe procedure risk death event lung transplantation chronic obstructive pulmonary disease individual
exacerbation use bronchodilator combination beta agonist medication inhaler spacer nebulizer nebulization oxygen supplementation
oxygen co level level consciousness
mouth chance recovery duration symptom steroid side effect day steroid work exacerbation antibiotics outcome number antibiotics amoxicillin fda use fluoroquinolone option risk side effect evidence case
people type failure level pressure ventilation probability death need care admission theophylline role measure hospital admission acidosis failure home care hospital home admission chronic obstructive pulmonary disease death person 2012 96116 236290 life year chronic obstructive pulmonary disease inhabitant data
770880 11001350
chronic obstructive pulmonary disease time death
disability chronic obstructive pulmonary disease proportion disability chronic obstructive pulmonary disease air quality asia number year disability chronic obstructive pulmonary disease
rate chronic obstructive pulmonary disease presence factor outcome airflow obstruction ability exercise shortness breath heart failure smoke outcome chronic obstructive pulmonary disease index score zero index distance minute mrc dyspnea scale weight loss sign result spirometry predictor progress disease index epidemiology
chronic obstructive pulmonary disease people population disease men women tobacco use women world increase world 2000 rate smoke region population population death cause disease country rate decrease chronic obstructive pulmonary disease prevalence number risk factor population
number death chronic obstructive pulmonary disease cause death 2012 cause number death country mortality men women due rate smoke women men chronic obstructive pulmonary disease people people year population review
england 084 people diagnosis chronic obstructive pulmonary disease person diagnosis chronic obstructive pulmonary disease point live
part country people chronic obstructive pulmonary disease area united states adult population people chronic obstructive pulmonary disease people chronic obstructive pulmonary disease case hospitalization united states chronic obstructive pulmonary disease united states chronic obstructive pulmonary disease cause death history giovanni battista description chronic obstructive pulmonary disease
word chronic obstructive pulmonary disease
mean breath blast term chronic obstructive pulmonary disease use term chronic obstructive pulmonary disease number name bronchopulmonary disease disease airflow obstruction airflow limitation chronic obstructive pulmonary disease disease syndrome
term chronic obstructive pulmonary disease chronic obstructive pulmonary disease guest symposium thoracic society committee meet standard
description chronic obstructive pulmonary disease t
bonet condition lung giovanni morgagni lung air draw chronic obstructive pulmonary disease picture matthew baillie description nature condition
charles catarrh cough mucus chronic obstructive pulmonary disease
physician stethoscope term chronic obstructive pulmonary disease book treatise disease chest lung chest autopsy
air airway mucus
john hutchinson spirometer measurement capacity lung
spirometer volume airflow
principle airflow
george l
allergist disease smoker syndrome journal association
association tobacco smoke disease
treatment garlic cinnamon ipecac treatment half century
evidence use steroid chronic obstructive pulmonary disease
use trial
bronchodilator salbutamol use laba society culture chronic obstructive pulmonary disease awareness month
chronic obstructive pulmonary disease smoker lung people people chronic obstructive pulmonary disease puffer type due complexion rate lip people chronic obstructive pulmonary disease type color skin lip oxygen level ankle terminology people chronic obstructive pulmonary disease combination chronic obstructive pulmonary disease chronic obstructive pulmonary disease
health system difficulty identification diagnosis care people chronic obstructive pulmonary disease britain department health issue health service strategy problem economics
chronic obstructive pulmonary disease result cost half world total cost care cost work year europe chronic obstructive pulmonary disease healthcare spend united states cost disease exacerbation chronic obstructive pulmonary disease condition hospital cost research chronic obstructive pulmonary disease journal chronic obstructive pulmonary disease
antibody chronic obstructive pulmonary disease possibility harm evidence benefit
inhibitor act
promise rate exacerbation person quality life side effect issue weight loss
sleep disturbance mood disturbance roflumilast pde4 therapy case failure standard chronic obstructive pulmonary disease treatment
long-act agent development treatment stem cell study data animal data data amount data result
procedure lung system supply lung data use effectiveness augmentation treatment people deficiency
research use telehealthcare people chronic obstructive pulmonary disease episode shortness breath people number visit person quality life animal
chronic obstructive pulmonary disease number animal exposure tobacco smoke case disease horse airway obstruction reaction fungus hay straw chronic obstructive pulmonary disease dog
